Mutations of the isocitrate dehydrogenase (IDH)1/2 genes are common events in gliomas (27), especially among grade II gliomas, where IDH1 mutations are observed in about 70% to 80% of cases (27, 28). The gene discussed is IDH3A; the disease is glioma.